Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...

RTTNews | 532天前

Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS

Amgen, Inc. (AMGN) announced Tuesday that the U.S. Food and Drug Administration (FDA) has completed its review of the company's supplemental New Drug Application seeking full approval of LUMAKRAS (sotorasib).

RTTNews | 688天前

Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4

Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.

RTTNews | 804天前

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen, Inc. (AMGN) announced Tuesday positive top-line results from the DAHLIA study, a randomized, double-blind, active-controlled, two-period crossover Phase 3 study evaluating the efficacy and safety of ABP 959, a biosimilar candidate to SOLIRIS (eculizumab), compared with SOLIRIS in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).

RTTNews | 1178天前

Bay Street Likely To Open On Mixed Note

Canadian shares are likely to open on a mixed note on Thursday, tracking earnings updates, and commodity prices. The end to the U.S. government shutdown following President Donald Trump signing a short term bill is likely to aid sentiment.

RTTNews | 1小時26分鐘前

European Stocks Pare Early Gains As Markets Digest Earnings, Economic News

European stocks gave up early gains and are broadly lower Thursday afternoon as investors look ahead to some crucial economic data following the longest federal government shutdown in U.S. history coming to an end after President Donald Trump signed a funding package.

RTTNews | 1小時51分鐘前

Disney Q4 Profit Beats Street, Revenues Miss; Sees Adj. EPS Growth, Plans $7 Bln Buyback; Stock Down

Shares of Walt Disney Co. were losing around 4 percent in the pre-market activity on Thursday after the media and entertainment major reported nearly flat revenues in its fourth quarter below market estimates, even though profit beat the Street. Further, the firm said it expects double digit year-over-year growth in adjusted earnings per share for fiscal 2026 and 2027, and targets doubling share

RTTNews | 2小時4分鐘前

FTSE 100 Moderately Lower At Noon As Investors React To Earnings, GDP Data

U.K.'s benchmark FTSE 100 is down in negative territory around noon on Thursday with investors digesting a slew of earnings updates, and data showing a marginal increase in the nation's economic growth in the third quarter.

RTTNews | 2小時45分鐘前

EURUSD	1.16219	GBPUSD	1.317	AUDUSD	0.65536
USDJPY	154.633	USDCAD	1.40061	USDCHF	0.79569